These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11753732)

  • 1. [Current status of perfluorocarbons].
    Welte M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Nov; 36 Suppl 2():S165-8. PubMed ID: 11753732
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternatives to allogeneic blood transfusions.
    Mulier M
    Acta Anaesthesiol Belg; 2002; 53(2):119-24. PubMed ID: 12146099
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical use of a blood substitute.
    Honda K; Hoshino S; Shoji M; Usuba A; Motoki R; Tsuboi M; Inoue H; Iwaya F
    N Engl J Med; 1980 Aug; 303(7):391-2. PubMed ID: 7393252
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prospects of treating acute circulatory hypoxia with perfluorocarbon emulsions].
    Goncharov OG; Kuznetsova IN; Sedova LA
    Vestn Khir Im I I Grek; 1986 Jun; 136(6):132-6. PubMed ID: 3750705
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood substitute passes its first test.
    Maugh TH
    Science; 1979 Oct; 206(4415):205. PubMed ID: 482936
    [No Abstract]   [Full Text] [Related]  

  • 6. Perfluorocarbons and haemoglobin solutions: will they ever reach clinical practice?
    Lamy M; Deby-Dupont G
    Acta Anaesthesiol Belg; 2003; 54(4):299-300. PubMed ID: 14719348
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current status of volume and oxygen carrier therapy].
    Standl T; Schulte Am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Nov; 36 Suppl 2():S69-70. PubMed ID: 11753701
    [No Abstract]   [Full Text] [Related]  

  • 8. Intra-abdominal sepsis and perfluorocarbons: mechanism of protection.
    Hoyt DB; Greenburg AG; Multer F; Coyle JJ; Saik RP; Long DM
    Curr Surg; 1982; 39(3):165-7. PubMed ID: 7094625
    [No Abstract]   [Full Text] [Related]  

  • 9. [Liquid ventilation with perfluorocarbons].
    Kohelet D; Arbel E
    Harefuah; 1998 Feb; 134(4):290-6. PubMed ID: 10909509
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxygen therapeutics: perfluorocarbons and blood substitute safety.
    Cohn CS; Cushing MM
    Crit Care Clin; 2009 Apr; 25(2):399-414, Table of Contents. PubMed ID: 19341916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative oxygen therapeutics: products, status of clinical trials, and future prospects.
    Winslow RM
    Curr Hematol Rep; 2003 Nov; 2(6):503-10. PubMed ID: 14561395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of oxygen carriers ('blood substitutes'): 2006.
    Winslow RM
    Vox Sang; 2006 Aug; 91(2):102-10. PubMed ID: 16907870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravenous perfluorocarbons: 30 years of research--what now?].
    Max M; Roissant R
    Dtsch Med Wochenschr; 2000 Apr; 125(15):444. PubMed ID: 10800440
    [No Abstract]   [Full Text] [Related]  

  • 14. [Artificial oxygen carriers -- a critical analysis of current developments].
    Dinkelmann S; Northoff H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):47-54. PubMed ID: 12522731
    [No Abstract]   [Full Text] [Related]  

  • 15. [Utilization of plasma-substitutes in various parts of Czechoslovakia in 1854-56].
    DOBRY E; GUTFREUNDOVA E; NOVAK J
    Cesk Zdrav; 1957 Dec; 5(12):710-5. PubMed ID: 13511545
    [No Abstract]   [Full Text] [Related]  

  • 16. [Plasma substitutes in clinical tuberculosis].
    TAMARIN IL
    Probl Tuberk; 1956; 34(Suppl 6):5-6. PubMed ID: 13420099
    [No Abstract]   [Full Text] [Related]  

  • 17. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status.
    Kim HW; Greenburg AG
    Artif Organs; 2004 Sep; 28(9):813-28. PubMed ID: 15320945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood substitutes and their therapeutic use].
    Vasil'ev PS; Suzdaleva VV
    Klin Med (Mosk); 1966 Jul; 44(7):20-2. PubMed ID: 5957588
    [No Abstract]   [Full Text] [Related]  

  • 19. Do plasma substitutes have additional properties beyond correcting volume deficits?: Shock 25:2103-116, 2006.
    Wiedermann CJ
    Shock; 2007 Mar; 27(3):339-42. PubMed ID: 17304118
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of perfluorochemicals on severe hemo-diluted cardiopulmonary bypass in dogs].
    Makino Y
    Hokkaido Igaku Zasshi; 2004 Jan; 79(1):41-6. PubMed ID: 14978973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.